Nestle has a newly-acquired company, and it is the protein shake maker, Orgain. The latter produces plant-based bars, shakes, and protein powders, and the Swiss multinational food and drink processing company headquartered in Vevey, Vaud, Switzerland, bought a majority stake for an undisclosed amount.
Andrew Abraham, Orgain's founder, and Butterfly Equity will remain shareholders of the company once the deal is completed. According to Food Dive, the agreement between Nestle and Orgain includes the option for the former to buy the rest of the shares in the company in 2024. Abraham will also retain his position as the chief executive officer of Orgain.
It was said that the stake acquisition will push and step up Nestlé's efforts to grow its health and wellness business unit. To attain its goal, the company will also be removing some of its divisions that are growing slowly compared to the others.
In fact, Nestlé already offloaded its confections and ice cream businesses and last year, it has also disposed of the majority of its North American bottled waters business for $4.3 billion as it was already struggling to stay afloat.
With its new deal with Orgain, Nestle will also be able to focus more on its other international premium brands that have big potential to grow further such as Perrier. Orgain will also give the firm fresh products to offer especially with the growing demand for plant-based items around the world. Furthermore, Orgain will give Nestle a deeper presence in trendy categories that are becoming really popular with consumers.
"Nutritional protein plays a key role in supporting our health and wellness, whether we enjoy an active lifestyle or are facing health challenges," Nestlé Health Science chief executive officer, Greg Behar, said in a press release. "Orgain's emphasis on clean, all natural, plant-based, organic ingredients has made it a leader in the U.S., and we look forward to combining our companies' expertise to bring Orgain to more people around the world."
Dr. Abraham, CEO and Founder of Orgain, also said, "We've worked hard to develop innovative products that make a real difference in consumers' lives, and now through Nestlé Health Science's capabilities, resources and dedication to nutrition, we will be able to reach more people around the world."
Meanwhile, the acquisition deal is still subject to customary regulatory approvals.


BOJ Rate Hike Expectations Rise Ahead of September Meeting
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Canada, US Hold Constructive Trade Talks as Tariff Negotiations Continue
Gold Prices Surge 7% as Dollar Falls, Fed Rate Hike Bets Ease
China Trade Surplus Beats Forecasts in July as Exports Stay Strong
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Gold Price Hits Seven-Week High as Fed Rate Hike Bets Fade and Hormuz Deal Hopes Grow
US Job Growth Seen Picking Up in July
Asian Stocks Slip as AI Rally Fades, Oil Holds Steady on Iran Peace Deal Hopes
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Gold Prices Steady as Hormuz Tensions Fuel Fed Rate Concerns
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
Asian Stocks Mixed as Chip Selloff Hits KOSPI, Nikkei Ahead of US Jobs Data 



